{"database": "openregs", "table": "cfr_sections", "is_view": false, "human_description_en": "where agency = \"FDA\" and part_number = 174 sorted by section_id", "rows": [["21:21:3.0.1.1.5.0.1.1", 21, "Food and Drugs", "I", "B", "174", "PART 174\u2014INDIRECT FOOD ADDITIVES: GENERAL", "", "", "", "\u00a7 174.5 General provisions applicable to indirect food additives.", "FDA", "", "", "[42 FR 14534, Mar. 15, 1977, as amended at 67 FR 35731, May 21, 2002]", "(a) Regulations prescribing conditions under which food additive substances may be safely used predicate usage under conditions of good manufacturing practice. For the purpose of this part and parts 175, 176, and 177 of this chapter, good manufacturing practice shall be defined to include the following restrictions:\n\n(1) The quantity of any food additive substance that may be added to food as a result of use in articles that contact food shall not exceed, where no limits are specified, that which results from use of the substance in an amount not more than reasonably required to accomplish the intended physical or technical effect in the food-contact article; shall not exceed any prescribed limitations; and shall not be intended to accomplish any physical or technical effect in the food itself, except as such may be permitted by regulations in parts 170 through 189 of this chapter.\n\n(2) Any substance used as a component of articles that contact food shall be of a purity suitable for its intended use.\n\n(b) The existence in the subchapter B of a regulation prescribing safe conditions for the use of a substance as an article or component of articles that contact food shall not be construed to relieve such use of the substance or article from compliance with any other provision of the Federal Food, Drug, and Cosmetic Act. For example, if a regulated food-packaging material were found on appropriate test to impart odor or taste to a specific food product such as to render it unfit within the meaning of section 402(a)(3) of the Act, the regulation would not be construed to relieve such use from compliance with section 402(a)(3).\n\n(c) The existence in this subchapter B of a regulation prescribing safe conditions for the use of a substance as an article or component of articles that contact food shall not be construed as implying that such substance may be safely used as a direct additive in food.\n\n(d) Substances that under conditions of good manufacturing practice may be safely used as components of articles that contact food include the following, subject to any prescribed limitations:\n\n(1) Substances generally recognized as safe in or on food.\n\n(2) Substances generally recognized as safe for their intended use in food packaging.\n\n(3) Substances used in accordance with a prior sanction or approval.\n\n(4) Substances permitted for use by regulations in this part and parts 175, 176, 177, 178 and \u00a7 179.45 of this chapter.\n\n(5) Food contact substances used in accordance with an effective premarket notification for a food contact substance (FCN) submitted under section 409(h) of the act."], ["21:21:3.0.1.1.5.0.1.2", 21, "Food and Drugs", "I", "B", "174", "PART 174\u2014INDIRECT FOOD ADDITIVES: GENERAL", "", "", "", "\u00a7 174.6 Threshold of regulation for substances used in food-contact articles.", "FDA", "", "", "[60 FR 36596, July 17, 1995]", "Substances used in food-contact articles (e.g., food-packaging or food-processing equipment) that migrate, or that may be expected to migrate, into food at negligible levels may be reviewed under \u00a7 170.39 of this chapter. The Food and Drug Administration will exempt substances whose uses it determines meet the criteria in \u00a7 170.39 of this chapter from regulation as food additives and, therefore, a food additive petition will not be required for the exempted use."]], "truncated": false, "filtered_table_rows_count": 2, "expanded_columns": [], "expandable_columns": [], "columns": ["section_id", "title_number", "title_name", "chapter", "subchapter", "part_number", "part_name", "subpart", "subpart_name", "section_number", "section_heading", "agency", "authority", "source_citation", "amendment_citations", "full_text"], "primary_keys": ["section_id"], "units": {}, "query": {"sql": "select section_id, title_number, title_name, chapter, subchapter, part_number, part_name, subpart, subpart_name, section_number, section_heading, agency, authority, source_citation, amendment_citations, full_text from cfr_sections where \"agency\" = :p0 and \"part_number\" = :p1 order by section_id limit 101", "params": {"p0": "FDA", "p1": "174"}}, "facet_results": {"title_number": {"name": "title_number", "type": "column", "hideable": false, "toggle_url": "/openregs/cfr_sections.json?agency=FDA&part_number=174", "results": [{"value": 21, "label": 21, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/cfr_sections.json?agency=FDA&part_number=174&title_number=21", "selected": false}], "truncated": false}, "agency": {"name": "agency", "type": "column", "hideable": false, "toggle_url": "/openregs/cfr_sections.json?agency=FDA&part_number=174", "results": [{"value": "FDA", "label": "FDA", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/cfr_sections.json?part_number=174", "selected": true}], "truncated": false}, "part_number": {"name": "part_number", "type": "column", "hideable": false, "toggle_url": "/openregs/cfr_sections.json?agency=FDA&part_number=174", "results": [{"value": "174", "label": "174", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/cfr_sections.json?agency=FDA", "selected": true}], "truncated": false}}, "suggested_facets": [], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 200.04048896953464, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}